この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1994/1/201 分で読めます
Antibody to Human T-Lymphotropic Virus Type I (HTLV-I) Reference Panel 3; Availability
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing the availability of a new FDA reference panel for tests intended to detect antibodies to Human T-Lymphotropic Virus Type I (HTLV-I Reference Panel 3). HTLV-I Reference Panel 3 is a regulatory test panel intended for lot release testing of enzyme-linked immunosorbent assay (ELISA) HTLV-I antibody test kits. The HTLV-I Reference Panel 3 is intended to replace HTLV-I Reference Panel 2F. FDA recommends that manufacturers of currently licensed HTLV-I test kits supplement their approved product license applications by amending their lot release protocols to use the HTLV-I Reference Panel 3.
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →